Reimagining Alzheimer’s Disease: New Thinking, New Choices - a podcast by ReachMD

CME credits: 0.50

Valid until: 04-01-2023

Claim your CME credit at https://reachmd.com/programs/cme/reimagining-alzheimers-disease-new-thinking-new-choices/13132/

Alzheimer’s disease (AD) is an irreversible, age-related, neurodegenerative disorder characterized by gradual decline in understanding, memory, and ability to perform activities of daily living. It is the most common cause of dementia worldwide and its’ prevalence continues to grow in part because of the aging world population. AD is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria including fluid and imaging biomarkers. Until recently, current therapies were limited to delaying cognitive decline in some patients, but not treating the underlying causes of the disease nor halting the progression of the disease. This program discusses recent advances in our understanding of the clinical evaluation for early and accurate diagnosis, newly approved and emerging disease-modifying therapies, as well as non-pharmacological strategies for the management of patients with AD.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD